Derma Sciences’ AMNIOEXCEL® Now Eligible for Reimbursement by Medicare Administrative Contractor NGS

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces that National Government Services (NGS), a Medicare Administrative Contractor (MAC) for Part B serving States primarily in the Northeast and Midwest, and National MAC for Jurisdiction 6, has retired its local coverage determination (LCD) for cellular or tissue-based products (CTPs) effective September 1, 2016. As a result, the Company’s AMNIOEXCEL® Amniotic Allograft Membrane (AMNIOEXCEL®) will be considered for coverage with appropriate documentation of medical necessity as a second-line therapy following standard wound care treatment.